UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Research Progress of BRAF Fusion in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2023-10, Vol.26 (10), p.782-788

2023

Volltextzugriff (PDF)

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

Frontiers in oncology, 2022-02, Vol.12, p.804330

2022

Volltextzugriff (PDF)

Chemotherapy-induced thrombocytopenia: literature review

Discover. Oncology, 2023-01, Vol.14 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

Current oncology (Toronto), 2022-10, Vol.29 (10), p.7411-7419

2022

Volltextzugriff (PDF)

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

Current oncology (Toronto), 2022-09, Vol.29 (10), p.6749-6753

2022

Volltextzugriff (PDF)

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

Frontiers in immunology, 2023-01, Vol.13, p.1068978

2023

Volltextzugriff (PDF)

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report

Frontiers in oncology, 2023-05, Vol.13, p.1159308

2023

Volltextzugriff (PDF)

Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancer

Translational oncology, 2022-10, Vol.24, p.101493, Article 101493

2022

Volltextzugriff (PDF)

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Chinese medical journal, 2023-06, Vol.136 (11), p.1370-1372

2023

Volltextzugriff (PDF)

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

BMC cancer, 2023-07, Vol.23 (1), p.609-609, Article 609

2023

Volltextzugriff (PDF)

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

Frontiers in oncology, 2022-12, Vol.12, p.1035808-1035808

2022

Volltextzugriff (PDF)

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression

Cell death & disease, 2024-05, Vol.15 (5), p.378-13, Article 378

2024

Volltextzugriff (PDF)

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review

Zhongguo fei ai za zhi, 2023-02, Vol.26 (2), p.158-164

2023

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review

Zhongguo fei ai za zhi, 2022-01, Vol.25 (1), p.61-65

2022

Volltextzugriff (PDF)

Correlation Analysis between Neutrophil-to-lymphocyte Ratio  and the Risk of Malnutrition in Stage IV Primary Lung Cancer

Zhongguo fei ai za zhi, 2024-03, Vol.27 (3), p.193-198

2024

Volltextzugriff (PDF)

Research Progress of Klotho in Lung Neoplasms

Zhongguo fei ai za zhi, 2023-06, Vol.26 (6), p.473-478

2023

Volltextzugriff (PDF)

Research Progress of Targeted Therapy for BRAF Mutation  in Advanced Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2018-08, Vol.21 (8), p.635-640

2018

Volltextzugriff (PDF)

A deep learning‐based interpretable decision tool for predicting high risk of chemotherapy‐induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy

Cancer medicine (Malden, MA), 2023-09, Vol.12 (17), p.18306-18316

2023

Volltextzugriff (PDF)

Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2020-03, Vol.23 (3), p.176-181

2020

Volltextzugriff (PDF)

Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC

Clinical and translational medicine, 2023-02, Vol.13 (2), p.e1191-n/a

2023

Volltextzugriff (PDF)

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

The Journal of biological chemistry, 2009-08, Vol.284 (35), p.23225-23233

2009

Volltextzugriff (PDF)

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920905424-1758835920905424

2020

Volltextzugriff (PDF)

Two Case Reports of Type 2 Diabetes Induced by Immune Checkpoint Inhibitors  Combined with Chemotherapy

Zhongguo fei ai za zhi, 2022-04, Vol.25 (4), p.287-290

2022

Volltextzugriff (PDF)

Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte‐colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study

Thoracic cancer, 2021-04, Vol.12 (8), p.1154-1161

2021

Volltextzugriff (PDF)

Lonafarnib is a potential inhibitor for neovascularization

PloS one, 2015-04, Vol.10 (4), p.e0122830-e0122830

2015

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

ThemaLung Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(103)
Berichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(54)
Humans
(45)
Oncology
(36)
Lung Neoplasms
(15)
Lung Neoplasms - Pathology
(15)
Cancer
(14)
Female
(13)
Lung Neoplasms - Genetics
(13)
Apoptosis
(11)
Cell Biology
(11)
Chemotherapy
(11)
Mutation
(11)
Cell Line, Tumor
(10)
Lung Neoplasms - Drug Therapy
(10)
Aged
(9)
Biochemistry & Molecular Biology
(9)
Carcinoma, Non-Small-Cell Lung - Pathology
(9)
Male
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Research Progress of BRAF Fusion in Non-small Cell Lung Cancer

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

Chemotherapy-induced thrombocytopenia: literature review

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report

Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancer

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review

Correlation Analysis between Neutrophil-to-lymphocyte Ratio  and the Risk of Malnutrition in Stage IV Primary Lung Cancer

Research Progress of Klotho in Lung Neoplasms

Research Progress of Targeted Therapy for BRAF Mutation  in Advanced Non-small Cell Lung Cancer

A deep learning‐based interpretable decision tool for predicting high risk of chemotherapy‐induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy

Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer

Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

Two Case Reports of Type 2 Diabetes Induced by Immune Checkpoint Inhibitors  Combined with Chemotherapy

Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte‐colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study

Lonafarnib is a potential inhibitor for neovascularization

Aktive Filter

Suchergebnisse filtern